Using the Scn1a+/– mouse model of Dravet syndrome, we have found several plant cannabinoids with novel anti-seizure effects. This evidence concerns the gene SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.